These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5523263)

  • 1. [Transitory myocardial ischemia with cardiogenic shock due to contrast medium intoleracne].
    Holldorf L
    Z Gesamte Inn Med; 1970 Apr; 25(8):369-70. PubMed ID: 5523263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled polycentric clinical study of a new sympathomimetic preparation: dimethophrine].
    Portioli I; Rocchi F; Bianchi G; Bianchini E; Dotti F; Lotto A; Bossi M; Uleri G; Zuccoli P; Ferrari M; Bigi N; Andreoli L; Tolva D; Anversa A; Volta G
    Clin Ter; 1971 Sep; 58(6):495-547. PubMed ID: 5156951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of a new sympathomimetic amine, dimethoprine].
    Arcidiacono R; Sanna GP
    Minerva Cardioangiol; 1972 Sep; 20(9):526-35. PubMed ID: 5071473
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.
    Mehta RH; Califf RM; Yang Q; Pieper KS; White HD; Ohman EM; Harrington RA; Granger CB
    Am J Cardiol; 2007 Mar; 99(6):793-6. PubMed ID: 17350367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucagon in cardiogenic shock].
    De Ninno F; Celentano V; Giugliano F
    Minerva Anestesiol; 1971 May; 37(5):240-6. PubMed ID: 5110768
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of action of new sympathomimetics (dopamine and wyamine) and the ir therapeutic possibilities in cardiogenic shock].
    Döring D
    Z Gesamte Inn Med; 1971 Jul; 26(13):Suppl:170-2. PubMed ID: 5125156
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of the antibiotic sibiromycin on the bioelectrical activity of the heart and the serum transaminase activity in dogs].
    Shepelevtseva NG
    Antibiotiki; 1975 Feb; 20(2):145-50. PubMed ID: 1119795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 2-[(5-chloro-2-methoxyphenyl)azo]-1H-imidazole (M6434) on hemorrhagic, cardiogenic, and endotoxin shock in rats and rabbits.
    Ohnishi H; Yamaguchi K; Sato M; Uemura A; Funato H; Dabasaki T
    Circ Shock; 1984; 13(3):261-70. PubMed ID: 6467523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduction in cardiotoxicity of ionic contrast media used in coronary angiography by added calcium--Clinical study (author's transl)].
    Zipfel J; Baller D; Blanke H; Jonas W; Karsch KR; Rentrop P; Hellige G
    Z Kardiol; 1980 Jun; 69(6):406-13. PubMed ID: 7445641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon in cardiogenic shock.
    Kones RJ; Dombeck DH; Phillips JH
    Angiology; 1972 Oct; 23(9):525-35. PubMed ID: 5079318
    [No Abstract]   [Full Text] [Related]  

  • 11. [Data on the effects of butydrine in patients with coronary insufficiency].
    De Maestri C; Rinaldi AR
    Minerva Cardioangiol; 1969 Feb; 17(2):142-50. PubMed ID: 5777638
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of myocardial contractions in chronic coronary insufficiency and under the effects of oxyphedrine].
    Ferreira Montero I; González Carretero M; Del Rio Ligorit A; La Figuera Benito E
    Rev Esp Cardiol; 1974; 27(5):391-9. PubMed ID: 4456468
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse reactions during urography and modification by atropine.
    Svendsen P; Wilson J
    Acta Radiol Diagn (Stockh); 1971 Jul; 11(4):427-33. PubMed ID: 5128591
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiotonic effects of glucagon].
    Robert M; Humair L
    Schweiz Med Wochenschr; 1970 Aug; 100(31):1345-52. PubMed ID: 5513359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ; Mathieson AL; Ducas J; Patton JN; Geddes JS; Prewitt RM
    Can J Cardiol; 1995 Jan; 11(1):30-6. PubMed ID: 7850662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse effects of a new non-ionic contrast medium in heart catheterization].
    Meyer GP; Trappe HJ; Jost S; Rafflenbeul W; Wenzlaff P; Lichtlen P
    Arzneimittelforschung; 1993 Aug; 43(8):932-4. PubMed ID: 8216457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular and blood chemical changes following the use of ioglycamide (bilivistan) in cholecysto- and cholangiography].
    Klemencic J; Kalitzsch J; Kark B
    Med Welt; 1971 Dec; 49():1969-70. PubMed ID: 5127506
    [No Abstract]   [Full Text] [Related]  

  • 19. [Occlusion of the right coronary artery with acute right heart infarct and cardiogenic shock].
    Tebbe U; Rahlf G; Sauer G; Kreuzer H; Neuhaus KL
    Z Kardiol; 1984 May; 73(5):327-32. PubMed ID: 6485465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
    Rokyta R; Pechman V
    Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.